French biotech Genticel lands $23.7M for ‘blockbuster’ HPV vaccine hopeful – FierceBiotech


VentureVillage
French biotech Genticel lands $23.7M for 'blockbuster' HPV vaccine hopeful
FierceBiotech
"The commitment from Wellington Partners, one of the most reputable life science investors in Europe, is further endorsement of Genticel's therapeutic HPV vaccine development," said Benedikt Timmerman, founder and CEO of Genticel, in a statement.
Wellington Partners invests €4m in HPV vaccine developer GenticelVentureVillage
Genticel Inks Over $20m Led by WellingtonPrivate Equity Hub (press release)
Wellington Partners leads € 18.2 million financing round at GenticelAngelNews (subscription) (press release)
unquote news (subscription)
all 5 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *